Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||
| Net Income | -30,768 | -13,947 | -9,915 |
| Depreciation Amortization | 1,052 | 487 | 354 |
| Other Working Capital | 5,376 | 552 | 99 |
| Other Operating Activity | 1,786 | 479 | 0 |
| Operating Cash Flow | $-22,554 | $-12,429 | $-9,462 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -4,677 | -1,758 | -409 |
| Purchase Of Investment | -31,573 | N/A | N/A |
| Sale Of Investment | 18,080 | N/A | 7,765 |
| Other Investing Activity | 0 | 20 | 9 |
| Investing Cash Flow | $-18,170 | $-1,738 | $7,366 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 50,741 | 23 | 33 |
| Other Financing Activity | 0 | 21,356 | 0 |
| Financing Cash Flow | $50,741 | $21,379 | $33 |
| Beginning Cash Position | 27,229 | 20,016 | 22,079 |
| End Cash Position | 37,246 | 27,229 | 20,016 |
| Net Cash Flow | $10,017 | $7,213 | $-2,063 |
| Free Cash Flow | |||
| Operating Cash Flow | -22,554 | -12,429 | -9,462 |
| Capital Expenditure | -4,677 | -1,758 | -409 |
| Free Cash Flow | -27,231 | -14,186 | -9,870 |